Glycemic Control in Patients with Diabetes Across Primary and Tertiary Government Health Sectors in the Emirate of Dubai, United Arab Emirates: A Five-Year Pattern

Overview

Journal Oman Med J

Specialty General Medicine

Date 2019 Jan 24

PMID 30671180

Citations 7

Authors

Fatheya Alawadi

Elamin Abdelgadir

Alaaeldin Bashier

Mohamed Hassanein

Fauzia Rashid

Maryam Alsaeed

Khadija Hafidh

Mohamed Abdellatif Elsayed

Sona Abuelkheir

Muhammad H Farooqi

Affiliations

Soon will be listed here.

Abstract

Objectives: In the UAE, the comparative prevalence of diabetes is reported as 18.98%, but there are very few studies evaluating glycemic control. Attaining the optimum glycemic control has been a global challenge over the years. However, there is a trend of global improvement with the availability of newer options of antidiabetic medications, increasing numbers of physicians, and patient awareness. Our primary aim was to assess the level of glycemic control across Dubai Health Authority points of care over the past five years. Additionally, we aimed to compare the differences in glycemic control between primary and tertiary centers, between nationalities, and type I and II diabetes.

Methods: We conducted a retrospective analysis of the electronic medical records of all patients who attended primary and tertiary care centers within the Dubai Health Authority between 2012 and 2016. All patients with any type of diabetes were included in this assessment.

Results: A total of 26 447 patients were included in the study; of these, 73.8% (n = 19 508) were UAE nationals while the other nationalities accounted for 26.2% (n = 6939) of patients. The overall mean glycated hemoglobin (HbA) levels from 2012 to 2016 was 7.76%. Patients attending primary care clinics had a mean HbA of 7.64% compared to 7.68% for the tertiary care cohort. Out of the total population, 37.7% achieved HbA < 7%. Over 40% of the patients attending primary care centers achieved HbA < 7% compared to 34.9% of those who attended tertiary care centers.

Conclusions: Optimum glycemic target was achieved by less than 40% of patients. Glycemic control is still below the desired levels. However, there has been a trend of improvement in the last few years and we are achieving the international average targets. Further collaborative actions from clinical, educational, and strategic sectors are needed to improve our goals further.

Citing Articles

Association between Dietary Pattern, Weight Loss, and Diabetes among Adults with a History of Bariatric Surgery: Results from the Qatar Biobank Study.

Almaghrbi R, Alyamani R, Aliwi L, Moawad J, Hussain A, Wang Y Nutrients. 2024; 16(14).

PMID: 39064637 PMC: 11279436. DOI: 10.3390/nu16142194.

Prevalence of Diabetic Retinopathy Among Individuals with Diabetes in Gulf Cooperation Council countries: A Systematic Review and  Meta-analysis.

Mohamed Z, Al-Natour M, Al Rahbi H Oman Med J. 2024; 39(1):e585.

PMID: 38651051 PMC: 11033453. DOI: 10.5001/omj.2024.77.

The Impact of Telemonitoring on Improving Glycemic and Metabolic Control in Previously Lost-to-Follow-Up Patients with Type 2 Diabetes Mellitus: A Single-Center Interventional Study in the United Arab Emirates.

Farooqi M, Abdelmannan D, Al Buflasa M, Abbas Hamed M, Xavier M, Santos Cadiz T Int J Clin Pract. 2022; 2022:6286574.

PMID: 35685530 PMC: 9159213. DOI: 10.1155/2022/6286574.

Management of Diabetes and Hypertension within the Gulf Region: Updates on Treatment Practices and Therapies.

Hassanein M, Akbar M, Al-Shamiri M, Amir A, Amod A, Chudleigh R Diabetes Ther. 2022; 13(7):1253-1280.

PMID: 35679010 PMC: 9178531. DOI: 10.1007/s13300-022-01282-4.

Current gaps in management and timely referral of cardiorenal complications among people with type 2 diabetes mellitus in the Middle East and African countries: Expert recommendations.

Sonmez A, Sabbour H, Echtay A, Rahmah A, Alhozali A, Al Sabaan F J Diabetes. 2022; 14(5):315-333.

PMID: 35434900 PMC: 9366572. DOI: 10.1111/1753-0407.13266.

References

King P, Peacock I, Donnelly R . The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999; 48(5):643-8. PMC: 2014359. DOI: 10.1046/j.1365-2125.1999.00092.x. View

Stratton I, Adler A, Neil H, Matthews D, Manley S, Cull C . Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321(7258):405-12. PMC: 27454. DOI: 10.1136/bmj.321.7258.405. View

Reed R, Revel A, Carter A, Saadi H, Dunn E . A clinical trial of chronic care diabetic clinics in general practice in the United Arab Emirates: a preliminary analysis. Arch Physiol Biochem. 2002; 109(3):272-80. DOI: 10.1076/apab.109.3.272.11591. View

Ezenwaka C, Offiah N . Differences in cardiovascular disease risk factors in elderly and younger patients with type 2 diabetes in the West Indies. Singapore Med J. 2003; 43(10):497-503. View

Saydah S, Fradkin J, Cowie C . Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004; 291(3):335-42. DOI: 10.1001/jama.291.3.335. View

Harris S, Ekoe J, Zdanowicz Y, Webster-Bogaert S . Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study). Diabetes Res Clin Pract. 2005; 70(1):90-7. DOI: 10.1016/j.diabres.2005.03.024. View

Afandi B, Ahmad S, Saadi H, Elkhumaidi S, Karkoukli M, Kelly B . Audit of a diabetes clinic at Tawam hospital, United Arab Emirates, 2004-2005. Ann N Y Acad Sci. 2006; 1084:319-24. DOI: 10.1196/annals.1372.017. View

Ong K, Cheung B, Wong L, Wat N, Tan K, Lam K . Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004. Ann Epidemiol. 2008; 18(3):222-9. DOI: 10.1016/j.annepidem.2007.10.007. View

Bi Y, Zhu D, Cheng J, Zhu Y, Xu N, Cui S . The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China. Clin Ther. 2010; 32(5):973-83. DOI: 10.1016/j.clinthera.2010.05.002. View

10.

Diab M, Johnson B, Hudson S . Adherence to clinical guidelines in management of diabetes and prevention of cardiovascular disease in Qatar. Int J Clin Pharm. 2012; 35(1):101-12. DOI: 10.1007/s11096-012-9714-3. View

11.

Shehab A, Elnour A, Abdulle A . A clinical audit on diabetes care in patients with type 2 diabetes in Al-ain, United arab emirates. Open Cardiovasc Med J. 2012; 6:126-32. PMC: 3486961. DOI: 10.2174/1874192401206010126. View

12.

Al-Taweel D, Awad A, Johnson B . Evaluation of adherence to international guidelines for treating patients with type 2 diabetes mellitus in Kuwait. Int J Clin Pharm. 2012; 35(2):244-50. DOI: 10.1007/s11096-012-9738-8. View

13.

Hermans M, Elisaf M, Michel G, Muls E, Nobels F, Vandenberghe H . Benchmarking is associated with improved quality of care in type 2 diabetes: the OPTIMISE randomized, controlled trial. Diabetes Care. 2013; 36(11):3388-95. PMC: 3816864. DOI: 10.2337/dc12-1853. View

14.

Inzucchi S, Bergenstal R, Buse J, Diamant M, Ferrannini E, Nauck M . Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2015; 58(3):429-42. DOI: 10.1007/s00125-014-3460-0. View

15.

Al Harbi T, Tourkmani A, Al-Khashan H, Mishriky A, Al Qahtani H, Bakhiet A . Adherence to the American Diabetes Association standards of care among patients with type 2 diabetes in primary care in Saudi Arabia. Saudi Med J. 2015; 36(2):221-7. PMC: 4375702. DOI: 10.15537/smj.2015.2.9603. View

16.

Klein R, Klein B, Moss S, Davis M, DeMets D . The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol. 1989; 107(2):244-9. DOI: 10.1001/archopht.1989.01070010250031. View

17.

. 6. Glycemic Targets: . Diabetes Care. 2017; 41(Suppl 1):S55-S64. DOI: 10.2337/dc18-S006. View

18.

Khunti K, Ceriello A, Cos X, De Block C . Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis. Diabetes Res Clin Pract. 2018; 137:137-148. DOI: 10.1016/j.diabres.2017.12.004. View

19.

Osenenko K, Szabo S, Qatami L, Korenblat Donato B, Al Madani A, Al Awadi F . Patterns of Care and Treatment Target Success among Persons with Type 2 Diabetes Mellitus in Dubai: A Retrospective Cohort Study. Value Health Reg Issues. 2018; 7:87-93. DOI: 10.1016/j.vhri.2015.08.006. View

20.

Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S . Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995; 28(2):103-17. DOI: 10.1016/0168-8227(95)01064-k. View